About Invitae
Industry:
Genetic Testing/Diagnostics
Founded:
2010
Founders:
Randy Scott, Sean George
Status:
Public (NASDAQ: NVTA)
Funding & Growth
Total Raised:
$2B+
Valuation:
$500M+ market cap
Stage:
Public
Key Investors:
ARCH Venture Partners
Casdin Capital
Deerfield Management
✓ Pros
- • Mission-driven company
- • Broad genetic testing menu
- • Large variant database
- • San Francisco location
- • Impact on patient care
✗ Cons
- • Financial challenges
- • Recent restructuring/layoffs
- • Integration of acquisitions
- • Reimbursement pressures